You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

Methoxsalen - Generic Drug Details

✉ Email this page to a colleague

« Back to Dashboard

What are the generic drug sources for methoxsalen and what is the scope of freedom to operate?

Methoxsalen is the generic ingredient in five branded drugs marketed by Valeant Pharm Intl, Actavis Inc, Ani Pharms, Strides Pharma, Bausch, and Mallinckrodt Hosp, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for methoxsalen. Two suppliers are listed for this compound.

Summary for methoxsalen

US Patents:	0
Tradenames:	5
Applicants:	6
NDAs:	6
Drug Master File Entries:	7
Finished Product Suppliers / Packagers:	2
Raw Ingredient (Bulk) Api Vendors:	150
Clinical Trials:	25
Patent Applications:	6,627
Formulation / Manufacturing:	see details
Drug Prices:	Drug price trends for methoxsalen
What excipients (inactive ingredients) are in methoxsalen?	methoxsalen excipients list
DailyMed Link:	methoxsalen at DailyMed

See drug prices for methoxsalen

Recent Clinical Trials for methoxsalen

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Georgetown University	Phase 2
European Organisation for Research and Treatment of Cancer - EORTC	Phase 2
Tyme, Inc	Phase 2

See all methoxsalen clinical trials

Pharmacology for methoxsalen

Drug Class	Photoactivated Radical Generator Psoralen
Mechanism of Action	Photoabsorption
Physiological Effect	Photosensitizing Activity

Medical Subject Heading (MeSH) Categories for methoxsalen

Cross-Linking Reagents
Photosensitizing Agents

US Patents and Regulatory Information for methoxsalen

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Bausch	OXSORALEN-ULTRA	methoxsalen	CAPSULE;ORAL	019600-001	Oct 30, 1986	AB	RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Valeant Pharm Intl	8-MOP	methoxsalen	CAPSULE;ORAL	009048-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Ani Pharms	METHOXSALEN	methoxsalen	CAPSULE;ORAL	087781-001	Jun 8, 1982		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Strides Pharma	METHOXSALEN	methoxsalen	CAPSULE;ORAL	202687-001	Jun 5, 2014	AB	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for methoxsalen

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Mallinckrodt Hosp	UVADEX	methoxsalen	INJECTABLE;INJECTION	020969-001	Feb 25, 1999	⤷ Try a Trial	⤷ Try a Trial
Mallinckrodt Hosp	UVADEX	methoxsalen	INJECTABLE;INJECTION	020969-001	Feb 25, 1999	⤷ Try a Trial	⤷ Try a Trial
Bausch	OXSORALEN-ULTRA	methoxsalen	CAPSULE;ORAL	019600-001	Oct 30, 1986	⤷ Try a Trial	⤷ Try a Trial
Mallinckrodt Hosp	UVADEX	methoxsalen	INJECTABLE;INJECTION	020969-001	Feb 25, 1999	⤷ Try a Trial	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.